http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100809391-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02B21-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02B21-368 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02B21-0008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02B21-025 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 |
filingDate | 2006-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2008-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2008-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-100809391-B1 |
titleOfInvention | Method for producing cationic antimicrobial peptide and use thereof |
abstract | The present invention is a method for mass production of cationic antimicrobial peptides, and more specifically, a human ketosteroid which is a binding protein by synthesizing and amplifying genes optimizing the gene structure of cationic antimicrobial peptides and the frequency of use of Messenger RNA of microorganisms. The combination of the isomerase gene and the histidine gene, which facilitates protein recovery, is sequentially linked to the N-terminus or C-terminus, and then the cationic antimicrobial peptide is expressed in a large amount in the expressing bacteria. It relates to a method of recovery. |
priorityDate | 2006-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 258.